← All organizations
Highest phase reached
Phase 3
Timeline
2010s
- Jan 1, 2011
Clearside Biomedical, Inc.— Founded
2020s
- Oct 22, 2021
triamcinolone— Marketing Organization
Drugs by trial phase (5 distinct, 11 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (20)
- NCT05891548Lead sponsorPhase 2May 31, 2023
- NCT05891548Study directorPhase 2May 31, 2023
- NCT04626128Study directorPhase 1/Phase 2Dec 15, 2020
- NCT04626128Lead sponsorPhase 1/Phase 2Dec 15, 2020
- NCT03203447Lead sponsorPhase 3Sep 1, 2017
- NCT03126786Lead sponsorPhase 2Jun 1, 2017
- NCT03097315Study directorPhase 3Apr 1, 2017
- NCT03097315Lead sponsorPhase 3Apr 1, 2017
- NCT02980874Lead sponsorPhase 3Jan 1, 2017
- NCT02980874Study directorPhase 3Jan 1, 2017
- NCT02949024Lead sponsorPhase 1/Phase 2Nov 1, 2016
- NCT02949024Study directorPhase 1/Phase 2Nov 1, 2016
- NCT02595398Lead sponsorPhase 3Nov 1, 2015
- NCT02595398Study directorPhase 3Nov 1, 2015
- NCT02303184Study directorPhase 2Jan 1, 2015
Details
- Founded
- Alparetta, GE Jan 1, 2011
- Last known activity
- May 31, 2023